Acousia to Present PROHEARÂ Study on Hearing Loss Treatment for Cancer Patients
The PROHEAR study is a placebo-controlled Phase 2a study investigating the otoprotective efficacy of ACOU085 in patients with testicular cancer undergoing cisplatin-based chemotherapy.